• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于多参数双能量非增强CT鉴别肝脏良恶性病变的预测模型

Prediction models for differentiating benign from malignant liver lesions based on multiparametric dual-energy non-contrast CT.

作者信息

Ota Takashi, Onishi Hiromitsu, Fukui Hideyuki, Tsuboyama Takahiro, Nakamoto Atsushi, Honda Toru, Matsumoto Shohei, Tatsumi Mitsuaki, Tomiyama Noriyuki

机构信息

Department of Diagnostic and Interventional Radiology, Osaka University Graduate School of Medicine, Osaka, Japan.

Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Osaka, Japan.

出版信息

Eur Radiol. 2025 Mar;35(3):1361-1377. doi: 10.1007/s00330-024-11024-8. Epub 2024 Aug 26.

DOI:10.1007/s00330-024-11024-8
PMID:39186105
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11836082/
Abstract

OBJECTIVES

To create prediction models (PMs) for distinguishing between benign and malignant liver lesions using quantitative data from dual-energy CT (DECT) without contrast agents.

MATERIALS AND METHODS

This retrospective study included patients with liver lesions who underwent DECT, including non-contrast-enhanced scans. Benign lesions included hepatic hemangioma, whereas malignant lesions included hepatocellular carcinoma, metastatic liver cancer, and intrahepatic cholangiocellular carcinoma. Patients were divided into derivation and validation groups. In the derivation group, two radiologists calculated ten multiparametric data using univariate and multivariate logistic regression to generate PMs. In the validation group, two additional radiologists measured the parameters to assess the diagnostic performance of PMs.

RESULTS

The study included 121 consecutive patients (mean age 67.4 ± 13.8 years, 80 males), with 97 in the derivation group (25 benign and 72 malignant) and 24 in the validation group (7 benign and 17 malignant). Oversampling increased the benign lesion sample to 75, equalizing the malignant group for building PMs. All parameters were statistically significant in univariate analysis (all p < 0.05), leading to the creation of five PMs in multivariate analysis. The area under the curve for the five PMs of two observers was as follows: PM1 (slope K, blood) = 0.76, 0.74; PM2 (slope K, fat) = 0.55, 0.51; PM3 (effective-Z difference, blood) = 0.75, 0.72; PM4 (slope K, blood, fat) = 0.82, 0.78; and PM5 (slope K, effective-Z difference, blood) = 0.90, 0.87. PM5 yielded the best diagnostic performance.

CONCLUSION

Multiparametric non-contrast-enhanced DECT is a highly effective method for distinguishing between liver lesions.

CLINICAL RELEVANCE STATEMENT

The utilization of non-contrast-enhanced DECT is extremely useful for distinguishing between benign and malignant liver lesions. This approach enables physicians to plan better treatment strategies, alleviating concerns associated with contrast allergy, contrast-induced nephropathy, radiation exposure, and excessive medical expenses.

KEY POINTS

Distinguishing benign from malignant liver lesions with non-contrast-enhanced CT would be desirable. This model, incorporating slope K, effective Z, and blood quantification, distinguished benign from malignant liver lesions. Non-contrast-enhanced DECT has benefits, particularly in patients with an iodine allergy, renal failure, or asthma.

摘要

目的

利用双能CT(DECT)的定量数据在无造影剂的情况下创建区分肝脏良性和恶性病变的预测模型(PMs)。

材料与方法

这项回顾性研究纳入了接受DECT检查(包括非增强扫描)的肝脏病变患者。良性病变包括肝血管瘤,而恶性病变包括肝细胞癌、转移性肝癌和肝内胆管细胞癌。患者被分为推导组和验证组。在推导组中,两名放射科医生使用单变量和多变量逻辑回归计算十个多参数数据以生成PMs。在验证组中,另外两名放射科医生测量参数以评估PMs的诊断性能。

结果

该研究纳入了121例连续患者(平均年龄67.4±13.8岁,男性80例),其中推导组97例(25例良性和72例恶性),验证组24例(7例良性和17例恶性)。过采样将良性病变样本增加到75例,使恶性组在构建PMs时达到平衡。所有参数在单变量分析中均具有统计学意义(所有p<0.05),在多变量分析中生成了五个PMs。两名观察者的五个PMs的曲线下面积如下:PM1(斜率K,血液)=0.76,0.74;PM2(斜率K,脂肪)=0.55,0.51;PM3(有效Z差值,血液)=0.75,0.72;PM4(斜率K,血液,脂肪)=0.82,0.78;PM5(斜率K,有效Z差值,血液)=0.90,0.87。PM5具有最佳的诊断性能。

结论

多参数非增强DECT是区分肝脏病变的高效方法。

临床相关性声明

非增强DECT的应用对于区分肝脏良性和恶性病变极为有用。这种方法使医生能够制定更好的治疗策略,减轻与造影剂过敏、造影剂肾病、辐射暴露和医疗费用过高相关的担忧。

关键点

使用非增强CT区分肝脏良性和恶性病变是可取的。该模型结合斜率K、有效Z和血液定量,区分了肝脏良性和恶性病变。非增强DECT有诸多益处,尤其对于碘过敏、肾衰竭或哮喘患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/573e/11836082/1ee0d50594d6/330_2024_11024_Fig6a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/573e/11836082/13f1f09d1252/330_2024_11024_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/573e/11836082/f1d5e328697d/330_2024_11024_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/573e/11836082/794e7ee383fa/330_2024_11024_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/573e/11836082/2f11ef042378/330_2024_11024_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/573e/11836082/ae16193f67f9/330_2024_11024_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/573e/11836082/1ee0d50594d6/330_2024_11024_Fig6a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/573e/11836082/13f1f09d1252/330_2024_11024_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/573e/11836082/f1d5e328697d/330_2024_11024_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/573e/11836082/794e7ee383fa/330_2024_11024_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/573e/11836082/2f11ef042378/330_2024_11024_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/573e/11836082/ae16193f67f9/330_2024_11024_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/573e/11836082/1ee0d50594d6/330_2024_11024_Fig6a_HTML.jpg

相似文献

1
Prediction models for differentiating benign from malignant liver lesions based on multiparametric dual-energy non-contrast CT.基于多参数双能量非增强CT鉴别肝脏良恶性病变的预测模型
Eur Radiol. 2025 Mar;35(3):1361-1377. doi: 10.1007/s00330-024-11024-8. Epub 2024 Aug 26.
2
Semiautomatic Segmentation and Radiomics for Dual-Energy CT: A Pilot Study to Differentiate Benign and Malignant Hepatic Lesions.基于双能 CT 的半自动分割和放射组学:鉴别良恶性肝脏病变的初步研究。
AJR Am J Roentgenol. 2020 Aug;215(2):398-405. doi: 10.2214/AJR.19.22164. Epub 2020 May 14.
3
Dual-energy CT in differentiating benign gallbladder wall thickening from wall thickening type of gallbladder cancer.双能CT在鉴别良性胆囊壁增厚与胆囊癌壁增厚型中的应用
Eur Radiol. 2025 Jan;35(1):84-92. doi: 10.1007/s00330-024-10904-3. Epub 2024 Jul 9.
4
Dual-energy CT in differentiating benign sinonasal lesions from malignant ones: comparison with simulated single-energy CT, conventional MRI, and DWI.双能量CT在鉴别鼻窦良性病变与恶性病变中的应用:与模拟单能量CT、传统MRI及DWI的比较
Eur Radiol. 2022 Feb;32(2):1095-1105. doi: 10.1007/s00330-021-08159-3. Epub 2021 Aug 24.
5
Characterization of Small Incidental Indeterminate Hypoattenuating Hepatic Lesions: Added Value of Single-Phase Contrast-Enhanced Dual-Energy CT Material Attenuation Analysis.小的偶然不确定低衰减肝病变的特征:单相对比增强双能 CT 物质衰减分析的附加价值。
AJR Am J Roentgenol. 2018 Sep;211(3):571-579. doi: 10.2214/AJR.17.19170. Epub 2018 Jul 24.
6
Diagnostic performance of dual-energy CT and subtraction CT for renal lesion detection and characterization.双能 CT 和减影 CT 对肾脏病变检测和特征描述的诊断性能。
Eur Radiol. 2019 Dec;29(12):6559-6570. doi: 10.1007/s00330-019-06224-6. Epub 2019 May 27.
7
Material density iodine images in dual-energy CT: Detection and characterization of hypervascular liver lesions compared to magnetic resonance imaging.双能 CT 下的物质密度碘图:与磁共振成像相比,对富血管性肝脏病变的检测和特征分析。
Eur J Radiol. 2017 Oct;95:300-306. doi: 10.1016/j.ejrad.2017.08.035. Epub 2017 Aug 31.
8
Dual-energy CT Radiomics Combined with Quantitative Parameters for Differentiating Lung Adenocarcinoma From Squamous Cell Carcinoma: A Dual-center Study.双能量CT影像组学联合定量参数鉴别肺腺癌与肺鳞癌:一项双中心研究
Acad Radiol. 2025 Mar;32(3):1675-1684. doi: 10.1016/j.acra.2024.09.024. Epub 2024 Sep 25.
9
Low kV versus dual-energy virtual monoenergetic CT imaging for proven liver lesions: what are the advantages and trade-offs in conspicuity and image quality? A pilot study.低千伏与双能虚拟单能量 CT 成像在证实的肝脏病变中的应用:在对比增强和图像质量方面的优势和权衡是什么?一项初步研究。
Abdom Radiol (NY). 2018 Jun;43(6):1404-1412. doi: 10.1007/s00261-017-1327-9.
10
Hypodense liver lesions in patients with hepatic steatosis: do we profit from dual-energy computed tomography?肝脂肪变性患者的肝脏低密病灶:我们是否能从双能 CT 中获益?
Eur Radiol. 2015 Dec;25(12):3567-76. doi: 10.1007/s00330-015-3772-6. Epub 2015 May 17.

引用本文的文献

1
Global research hotspots and trends of iodinated contrast agents in medical imaging: a bibliometric and visualization analysis.医学成像中碘化造影剂的全球研究热点与趋势:文献计量学与可视化分析
Front Med (Lausanne). 2024 Nov 22;11:1506634. doi: 10.3389/fmed.2024.1506634. eCollection 2024.

本文引用的文献

1
Focal Lesions of the Liver and Radiomics: What Do We Know?肝脏局灶性病变与影像组学:我们了解什么?
Diagnostics (Basel). 2023 Aug 3;13(15):2591. doi: 10.3390/diagnostics13152591.
2
Shortage of iodinated contrast media: Status and possible chances - A systematic review.碘对比剂短缺:现状与可能的机会——系统评价。
Eur J Radiol. 2023 Jul;164:110853. doi: 10.1016/j.ejrad.2023.110853. Epub 2023 May 3.
3
Liver Metastases: Correlation between Imaging Features and Pathomolecular Environments.肝转移瘤:影像学特征与病理分子环境的相关性。
Radiographics. 2022 Nov-Dec;42(7):1994-2013. doi: 10.1148/rg.220056. Epub 2022 Sep 23.
4
Radiomics Analysis on Noncontrast CT for Distinguishing Hepatic Hemangioma (HH) and Hepatocellular Carcinoma (HCC).基于平扫 CT 的影像组学分析鉴别肝血管瘤(HH)与肝细胞癌(HCC)
Contrast Media Mol Imaging. 2022 Jun 25;2022:7693631. doi: 10.1155/2022/7693631. eCollection 2022.
5
Radiomics Study for Differentiating Focal Hepatic Lesions Based on Unenhanced CT Images.基于平扫CT图像鉴别肝脏局灶性病变的影像组学研究
Front Oncol. 2022 Apr 27;12:650797. doi: 10.3389/fonc.2022.650797. eCollection 2022.
6
Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI.肝内肿块型胆管细胞癌及其模拟病变的影像学表现:MRI 如何对其进行鉴别。
Curr Oncol. 2022 Jan 30;29(2):698-723. doi: 10.3390/curroncol29020061.
7
Dual-source dual-energy computed tomography-derived quantitative parameters combined with machine learning for the differential diagnosis of benign and malignant thyroid nodules.双源双能量计算机断层扫描衍生的定量参数联合机器学习用于甲状腺良恶性结节的鉴别诊断
Quant Imaging Med Surg. 2022 Feb;12(2):967-978. doi: 10.21037/qims-21-501.
8
Differentiation of malignant from benign orbital tumours using dual-energy CT.应用双能量 CT 对眼眶良恶性肿瘤进行鉴别诊断。
Clin Radiol. 2022 Apr;77(4):307-313. doi: 10.1016/j.crad.2021.12.019. Epub 2022 Jan 31.
9
Multimaterial decomposition algorithm for quantification of fat in hepatocellular carcinoma using rapid kilovoltage-switching dual-energy CT: A comparison with chemical-shift MR imaging.基于快速千伏切换双能 CT 的肝细胞癌中脂肪定量的多物质分解算法:与化学位移磁共振成像的比较。
Medicine (Baltimore). 2021 May 21;100(20):e26109. doi: 10.1097/MD.0000000000026109.
10
Dual-energy CT quantitative parameters for the differentiation of benign from malignant lesions and the prediction of histopathological and molecular subtypes in breast cancer.双能CT定量参数在乳腺癌良恶性病变鉴别及组织病理学和分子亚型预测中的应用
Quant Imaging Med Surg. 2021 May;11(5):1946-1957. doi: 10.21037/qims-20-825.